nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—GRIN2B—Alzheimer's disease	0.23	0.733	CbGaD
Ketamine—GRIN1—Memantine—Alzheimer's disease	0.128	0.257	CbGbCtD
Ketamine—GRIN2A—Memantine—Alzheimer's disease	0.117	0.234	CbGbCtD
Ketamine—GRIN2B—Memantine—Alzheimer's disease	0.117	0.234	CbGbCtD
Ketamine—PTGS1—Alzheimer's disease	0.0837	0.267	CbGaD
Ketamine—GRIN3A—Memantine—Alzheimer's disease	0.0776	0.156	CbGbCtD
Ketamine—DRD2—Memantine—Alzheimer's disease	0.0199	0.04	CbGbCtD
Ketamine—CYP2B6—Memantine—Alzheimer's disease	0.0149	0.0299	CbGbCtD
Ketamine—CYP2C9—Donepezil—Alzheimer's disease	0.00908	0.0182	CbGbCtD
Ketamine—CYP3A4—Rivastigmine—Alzheimer's disease	0.00661	0.0132	CbGbCtD
Ketamine—CYP3A4—Donepezil—Alzheimer's disease	0.00528	0.0106	CbGbCtD
Ketamine—GRIN1—telencephalic ventricle—Alzheimer's disease	0.00365	0.073	CbGeAlD
Ketamine—GRIN2B—telencephalic ventricle—Alzheimer's disease	0.00348	0.0696	CbGeAlD
Ketamine—CYP3A4—Galantamine—Alzheimer's disease	0.0034	0.00682	CbGbCtD
Ketamine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00286	0.0571	CbGeAlD
Ketamine—Epilepsy—Rivastigmine—Alzheimer's disease	0.00262	0.0569	CcSEcCtD
Ketamine—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00185	0.037	CbGeAlD
Ketamine—Nystagmus—Donepezil—Alzheimer's disease	0.00157	0.0341	CcSEcCtD
Ketamine—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00141	0.0307	CcSEcCtD
Ketamine—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.0014	0.0305	CcSEcCtD
Ketamine—Cystitis—Galantamine—Alzheimer's disease	0.0014	0.0304	CcSEcCtD
Ketamine—Nystagmus—Rivastigmine—Alzheimer's disease	0.00139	0.0303	CcSEcCtD
Ketamine—Bladder pain—Galantamine—Alzheimer's disease	0.00131	0.0284	CcSEcCtD
Ketamine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00123	0.0247	CbGeAlD
Ketamine—Apnoea—Memantine—Alzheimer's disease	0.0012	0.0261	CcSEcCtD
Ketamine—Apnoea—Rivastigmine—Alzheimer's disease	0.00117	0.0255	CcSEcCtD
Ketamine—GRIN2C—forebrain—Alzheimer's disease	0.00115	0.023	CbGeAlD
Ketamine—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00109	0.0238	CcSEcCtD
Ketamine—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.00109	0.0237	CcSEcCtD
Ketamine—Cystitis—Donepezil—Alzheimer's disease	0.00108	0.0235	CcSEcCtD
Ketamine—GRIN2D—forebrain—Alzheimer's disease	0.00107	0.0214	CbGeAlD
Ketamine—GRIN2C—telencephalon—Alzheimer's disease	0.00106	0.0212	CbGeAlD
Ketamine—Bladder pain—Donepezil—Alzheimer's disease	0.00101	0.022	CcSEcCtD
Ketamine—GRIN3A—forebrain—Alzheimer's disease	0.00101	0.0201	CbGeAlD
Ketamine—Cystitis noninfective—Memantine—Alzheimer's disease	0.000993	0.0216	CcSEcCtD
Ketamine—GRIN2D—telencephalon—Alzheimer's disease	0.000983	0.0197	CbGeAlD
Ketamine—Cystitis—Memantine—Alzheimer's disease	0.000982	0.0214	CcSEcCtD
Ketamine—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.000972	0.0211	CcSEcCtD
Ketamine—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000966	0.021	CcSEcCtD
Ketamine—Cystitis—Rivastigmine—Alzheimer's disease	0.000961	0.0209	CcSEcCtD
Ketamine—GRIN1—forebrain—Alzheimer's disease	0.000953	0.0191	CbGeAlD
Ketamine—GRIN3A—telencephalon—Alzheimer's disease	0.000924	0.0185	CbGeAlD
Ketamine—Bladder pain—Memantine—Alzheimer's disease	0.000919	0.02	CcSEcCtD
Ketamine—GRIN2B—forebrain—Alzheimer's disease	0.000909	0.0182	CbGeAlD
Ketamine—Bladder pain—Rivastigmine—Alzheimer's disease	0.000899	0.0196	CcSEcCtD
Ketamine—GRIN1—telencephalon—Alzheimer's disease	0.000876	0.0175	CbGeAlD
Ketamine—TACR1—forebrain—Alzheimer's disease	0.000872	0.0174	CbGeAlD
Ketamine—GRIN2B—telencephalon—Alzheimer's disease	0.000836	0.0167	CbGeAlD
Ketamine—TACR1—telencephalon—Alzheimer's disease	0.000802	0.016	CbGeAlD
Ketamine—GRIN2A—forebrain—Alzheimer's disease	0.000795	0.0159	CbGeAlD
Ketamine—Bradycardia—Galantamine—Alzheimer's disease	0.000739	0.0161	CcSEcCtD
Ketamine—Diplopia—Memantine—Alzheimer's disease	0.000738	0.0161	CcSEcCtD
Ketamine—GRIN2A—telencephalon—Alzheimer's disease	0.000731	0.0146	CbGeAlD
Ketamine—Diplopia—Rivastigmine—Alzheimer's disease	0.000722	0.0157	CcSEcCtD
Ketamine—OPRD1—forebrain—Alzheimer's disease	0.000708	0.0142	CbGeAlD
Ketamine—OPRK1—forebrain—Alzheimer's disease	0.000679	0.0136	CbGeAlD
Ketamine—OPRD1—telencephalon—Alzheimer's disease	0.000651	0.013	CbGeAlD
Ketamine—Arrhythmia—Galantamine—Alzheimer's disease	0.000648	0.0141	CcSEcCtD
Ketamine—GRIN2C—nervous system—Alzheimer's disease	0.000624	0.0125	CbGeAlD
Ketamine—GRIN2C—central nervous system—Alzheimer's disease	0.000601	0.012	CbGeAlD
Ketamine—Vision blurred—Galantamine—Alzheimer's disease	0.000595	0.013	CcSEcCtD
Ketamine—GRIN2C—cerebellum—Alzheimer's disease	0.000588	0.0118	CbGeAlD
Ketamine—GRIN2D—nervous system—Alzheimer's disease	0.00058	0.0116	CbGeAlD
Ketamine—Bradycardia—Donepezil—Alzheimer's disease	0.000573	0.0125	CcSEcCtD
Ketamine—GRIN2D—central nervous system—Alzheimer's disease	0.000559	0.0112	CbGeAlD
Ketamine—Convulsion—Galantamine—Alzheimer's disease	0.000547	0.0119	CcSEcCtD
Ketamine—GRIN2D—cerebellum—Alzheimer's disease	0.000546	0.0109	CbGeAlD
Ketamine—GRIN3A—nervous system—Alzheimer's disease	0.000546	0.0109	CbGeAlD
Ketamine—GRIN3A—central nervous system—Alzheimer's disease	0.000525	0.0105	CbGeAlD
Ketamine—Bradycardia—Memantine—Alzheimer's disease	0.00052	0.0113	CcSEcCtD
Ketamine—GRIN1—nervous system—Alzheimer's disease	0.000517	0.0103	CbGeAlD
Ketamine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000509	0.0111	CcSEcCtD
Ketamine—Shock—Galantamine—Alzheimer's disease	0.000507	0.011	CcSEcCtD
Ketamine—Arrhythmia—Donepezil—Alzheimer's disease	0.000502	0.0109	CcSEcCtD
Ketamine—GRIN1—central nervous system—Alzheimer's disease	0.000498	0.00996	CbGeAlD
Ketamine—GRIN2B—nervous system—Alzheimer's disease	0.000494	0.00987	CbGeAlD
Ketamine—Anorexia—Galantamine—Alzheimer's disease	0.000491	0.0107	CcSEcCtD
Ketamine—Erythema—Donepezil—Alzheimer's disease	0.00049	0.0107	CcSEcCtD
Ketamine—GRIN1—cerebellum—Alzheimer's disease	0.000487	0.00974	CbGeAlD
Ketamine—OPRM1—forebrain—Alzheimer's disease	0.000483	0.00966	CbGeAlD
Ketamine—Hypotension—Galantamine—Alzheimer's disease	0.000482	0.0105	CcSEcCtD
Ketamine—GRIN2C—brain—Alzheimer's disease	0.000477	0.00955	CbGeAlD
Ketamine—GRIN2B—central nervous system—Alzheimer's disease	0.000475	0.0095	CbGeAlD
Ketamine—TACR1—nervous system—Alzheimer's disease	0.000473	0.00946	CbGeAlD
Ketamine—GRIN2B—cerebellum—Alzheimer's disease	0.000464	0.00929	CbGeAlD
Ketamine—Vision blurred—Donepezil—Alzheimer's disease	0.000461	0.01	CcSEcCtD
Ketamine—Arrhythmia—Memantine—Alzheimer's disease	0.000456	0.00993	CcSEcCtD
Ketamine—TACR1—central nervous system—Alzheimer's disease	0.000456	0.00911	CbGeAlD
Ketamine—Decreased appetite—Galantamine—Alzheimer's disease	0.000448	0.00975	CcSEcCtD
Ketamine—PTGS1—blood vessel—Alzheimer's disease	0.000447	0.00893	CbGeAlD
Ketamine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000446	0.00971	CcSEcCtD
Ketamine—OPRM1—telencephalon—Alzheimer's disease	0.000444	0.00888	CbGeAlD
Ketamine—GRIN2D—brain—Alzheimer's disease	0.000444	0.00887	CbGeAlD
Ketamine—Erythema—Rivastigmine—Alzheimer's disease	0.000435	0.00946	CcSEcCtD
Ketamine—GRIN2A—nervous system—Alzheimer's disease	0.000431	0.00863	CbGeAlD
Ketamine—Convulsion—Donepezil—Alzheimer's disease	0.000424	0.00923	CcSEcCtD
Ketamine—Vision blurred—Memantine—Alzheimer's disease	0.000419	0.00912	CcSEcCtD
Ketamine—GRIN3A—brain—Alzheimer's disease	0.000417	0.00834	CbGeAlD
Ketamine—GRIN2A—central nervous system—Alzheimer's disease	0.000415	0.00831	CbGeAlD
Ketamine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00041	0.00892	CcSEcCtD
Ketamine—GRIN2A—cerebellum—Alzheimer's disease	0.000406	0.00812	CbGeAlD
Ketamine—GRIN1—brain—Alzheimer's disease	0.000395	0.00791	CbGeAlD
Ketamine—Shock—Donepezil—Alzheimer's disease	0.000393	0.00855	CcSEcCtD
Ketamine—Convulsion—Memantine—Alzheimer's disease	0.000385	0.00838	CcSEcCtD
Ketamine—OPRD1—nervous system—Alzheimer's disease	0.000385	0.00769	CbGeAlD
Ketamine—Anorexia—Donepezil—Alzheimer's disease	0.000381	0.00829	CcSEcCtD
Ketamine—GRIN2B—brain—Alzheimer's disease	0.000377	0.00755	CbGeAlD
Ketamine—Convulsion—Rivastigmine—Alzheimer's disease	0.000377	0.0082	CcSEcCtD
Ketamine—Hypotension—Donepezil—Alzheimer's disease	0.000373	0.00812	CcSEcCtD
Ketamine—OPRD1—central nervous system—Alzheimer's disease	0.00037	0.0074	CbGeAlD
Ketamine—OPRK1—nervous system—Alzheimer's disease	0.000369	0.00737	CbGeAlD
Ketamine—TACR1—brain—Alzheimer's disease	0.000362	0.00723	CbGeAlD
Ketamine—Shock—Memantine—Alzheimer's disease	0.000357	0.00777	CcSEcCtD
Ketamine—OPRK1—central nervous system—Alzheimer's disease	0.000355	0.0071	CbGeAlD
Ketamine—SLC6A2—forebrain—Alzheimer's disease	0.000354	0.00707	CbGeAlD
Ketamine—Shock—Rivastigmine—Alzheimer's disease	0.000349	0.0076	CcSEcCtD
Ketamine—Decreased appetite—Donepezil—Alzheimer's disease	0.000347	0.00756	CcSEcCtD
Ketamine—OPRK1—cerebellum—Alzheimer's disease	0.000347	0.00694	CbGeAlD
Ketamine—Anorexia—Memantine—Alzheimer's disease	0.000346	0.00753	CcSEcCtD
Ketamine—Pain—Donepezil—Alzheimer's disease	0.000342	0.00744	CcSEcCtD
Ketamine—Hypotension—Memantine—Alzheimer's disease	0.000339	0.00738	CcSEcCtD
Ketamine—Anorexia—Rivastigmine—Alzheimer's disease	0.000338	0.00736	CcSEcCtD
Ketamine—Hypotension—Rivastigmine—Alzheimer's disease	0.000332	0.00722	CcSEcCtD
Ketamine—GRIN2A—brain—Alzheimer's disease	0.00033	0.0066	CbGeAlD
Ketamine—Vomiting—Galantamine—Alzheimer's disease	0.000328	0.00713	CcSEcCtD
Ketamine—SLC6A2—telencephalon—Alzheimer's disease	0.000325	0.00651	CbGeAlD
Ketamine—Rash—Galantamine—Alzheimer's disease	0.000325	0.00707	CcSEcCtD
Ketamine—Dermatitis—Galantamine—Alzheimer's disease	0.000325	0.00707	CcSEcCtD
Ketamine—DRD2—forebrain—Alzheimer's disease	0.000322	0.00645	CbGeAlD
Ketamine—Decreased appetite—Memantine—Alzheimer's disease	0.000315	0.00686	CcSEcCtD
Ketamine—Pain—Memantine—Alzheimer's disease	0.00031	0.00675	CcSEcCtD
Ketamine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000309	0.00671	CcSEcCtD
Ketamine—Nausea—Galantamine—Alzheimer's disease	0.000306	0.00666	CcSEcCtD
Ketamine—Pain—Rivastigmine—Alzheimer's disease	0.000303	0.0066	CcSEcCtD
Ketamine—DRD2—telencephalon—Alzheimer's disease	0.000296	0.00593	CbGeAlD
Ketamine—OPRD1—brain—Alzheimer's disease	0.000294	0.00588	CbGeAlD
Ketamine—OPRK1—brain—Alzheimer's disease	0.000282	0.00564	CbGeAlD
Ketamine—ABCB1—blood vessel—Alzheimer's disease	0.000264	0.00528	CbGeAlD
Ketamine—OPRM1—nervous system—Alzheimer's disease	0.000262	0.00525	CbGeAlD
Ketamine—Vomiting—Donepezil—Alzheimer's disease	0.000254	0.00553	CcSEcCtD
Ketamine—OPRM1—central nervous system—Alzheimer's disease	0.000252	0.00505	CbGeAlD
Ketamine—Rash—Donepezil—Alzheimer's disease	0.000252	0.00548	CcSEcCtD
Ketamine—Dermatitis—Donepezil—Alzheimer's disease	0.000252	0.00548	CcSEcCtD
Ketamine—Nausea—Donepezil—Alzheimer's disease	0.000237	0.00516	CcSEcCtD
Ketamine—PTGS1—forebrain—Alzheimer's disease	0.000236	0.00471	CbGeAlD
Ketamine—Vomiting—Memantine—Alzheimer's disease	0.000231	0.00502	CcSEcCtD
Ketamine—Rash—Memantine—Alzheimer's disease	0.000229	0.00498	CcSEcCtD
Ketamine—Dermatitis—Memantine—Alzheimer's disease	0.000229	0.00497	CcSEcCtD
Ketamine—Vomiting—Rivastigmine—Alzheimer's disease	0.000226	0.00491	CcSEcCtD
Ketamine—Rash—Rivastigmine—Alzheimer's disease	0.000224	0.00487	CcSEcCtD
Ketamine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000224	0.00486	CcSEcCtD
Ketamine—PTGS1—telencephalon—Alzheimer's disease	0.000217	0.00433	CbGeAlD
Ketamine—Nausea—Memantine—Alzheimer's disease	0.000215	0.00469	CcSEcCtD
Ketamine—Nausea—Rivastigmine—Alzheimer's disease	0.000211	0.00459	CcSEcCtD
Ketamine—OPRM1—brain—Alzheimer's disease	0.0002	0.00401	CbGeAlD
Ketamine—SLC6A2—nervous system—Alzheimer's disease	0.000192	0.00384	CbGeAlD
Ketamine—SLC6A2—central nervous system—Alzheimer's disease	0.000185	0.0037	CbGeAlD
Ketamine—DRD2—nervous system—Alzheimer's disease	0.000175	0.0035	CbGeAlD
Ketamine—DRD2—central nervous system—Alzheimer's disease	0.000168	0.00337	CbGeAlD
Ketamine—DRD2—cerebellum—Alzheimer's disease	0.000165	0.00329	CbGeAlD
Ketamine—ABCB1—embryo—Alzheimer's disease	0.000158	0.00315	CbGeAlD
Ketamine—SLC6A2—brain—Alzheimer's disease	0.000147	0.00294	CbGeAlD
Ketamine—CYP2B6—nervous system—Alzheimer's disease	0.000141	0.00283	CbGeAlD
Ketamine—ABCB1—forebrain—Alzheimer's disease	0.000139	0.00279	CbGeAlD
Ketamine—CYP2B6—central nervous system—Alzheimer's disease	0.000136	0.00272	CbGeAlD
Ketamine—DRD2—brain—Alzheimer's disease	0.000134	0.00268	CbGeAlD
Ketamine—ABCB1—telencephalon—Alzheimer's disease	0.000128	0.00256	CbGeAlD
Ketamine—PTGS1—nervous system—Alzheimer's disease	0.000128	0.00256	CbGeAlD
Ketamine—PTGS1—central nervous system—Alzheimer's disease	0.000123	0.00246	CbGeAlD
Ketamine—CYP2C8—brain—Alzheimer's disease	0.000121	0.00241	CbGeAlD
Ketamine—CYP2B6—brain—Alzheimer's disease	0.000108	0.00216	CbGeAlD
Ketamine—CYP3A4—nervous system—Alzheimer's disease	0.000107	0.00214	CbGeAlD
Ketamine—CYP3A4—central nervous system—Alzheimer's disease	0.000103	0.00206	CbGeAlD
Ketamine—PTGS1—brain—Alzheimer's disease	9.78e-05	0.00196	CbGeAlD
Ketamine—ABCB1—nervous system—Alzheimer's disease	7.56e-05	0.00151	CbGeAlD
Ketamine—ABCB1—central nervous system—Alzheimer's disease	7.28e-05	0.00146	CbGeAlD
Ketamine—ABCB1—cerebellum—Alzheimer's disease	7.12e-05	0.00142	CbGeAlD
Ketamine—ABCB1—brain—Alzheimer's disease	5.78e-05	0.00116	CbGeAlD
Ketamine—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	3.02e-06	3.28e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HMOX1—Alzheimer's disease	3.02e-06	3.28e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VEGFA—Alzheimer's disease	3e-06	3.26e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SST—Alzheimer's disease	3e-06	3.26e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GAB2—Alzheimer's disease	3e-06	3.26e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NTRK2—Alzheimer's disease	3e-06	3.26e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	2.99e-06	3.25e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	2.99e-06	3.25e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	2.99e-06	3.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CALM1—Alzheimer's disease	2.99e-06	3.25e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	2.99e-06	3.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GSK3A—Alzheimer's disease	2.97e-06	3.23e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.96e-06	3.21e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	2.95e-06	3.21e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—F2—Alzheimer's disease	2.95e-06	3.21e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	2.93e-06	3.19e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APP—Alzheimer's disease	2.92e-06	3.18e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.92e-06	3.18e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.89e-06	3.14e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	2.89e-06	3.14e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	2.87e-06	3.12e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—A2M—Alzheimer's disease	2.86e-06	3.1e-05	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.86e-06	3.1e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ACHE—Alzheimer's disease	2.85e-06	3.1e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	2.82e-06	3.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—F2—Alzheimer's disease	2.81e-06	3.05e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	2.77e-06	3.01e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	2.77e-06	3.01e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	2.76e-06	3e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—LPL—Alzheimer's disease	2.76e-06	3e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	2.76e-06	3e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	2.76e-06	2.99e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TGFB1—Alzheimer's disease	2.75e-06	2.99e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	2.75e-06	2.98e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	2.75e-06	2.98e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	2.74e-06	2.98e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.73e-06	2.97e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	2.72e-06	2.96e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	2.71e-06	2.95e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.71e-06	2.94e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	2.69e-06	2.93e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	2.69e-06	2.92e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	2.68e-06	2.92e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—INS—Alzheimer's disease	2.68e-06	2.91e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	2.67e-06	2.9e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ENO1—Alzheimer's disease	2.67e-06	2.9e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—A2M—Alzheimer's disease	2.67e-06	2.9e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	2.63e-06	2.86e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	2.62e-06	2.85e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	2.62e-06	2.85e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	2.62e-06	2.85e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—F2—Alzheimer's disease	2.59e-06	2.81e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	2.59e-06	2.81e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	2.57e-06	2.8e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	2.56e-06	2.78e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	2.55e-06	2.77e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.53e-06	2.75e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	2.51e-06	2.73e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	2.5e-06	2.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	2.5e-06	2.71e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—MTHFR—Alzheimer's disease	2.49e-06	2.7e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ACHE—Alzheimer's disease	2.48e-06	2.7e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—BCHE—Alzheimer's disease	2.48e-06	2.7e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	2.46e-06	2.67e-05	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.41e-06	2.62e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.38e-06	2.59e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	2.38e-06	2.58e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—S100B—Alzheimer's disease	2.38e-06	2.58e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	2.36e-06	2.56e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	2.35e-06	2.55e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—INS—Alzheimer's disease	2.35e-06	2.55e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	2.34e-06	2.55e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	2.33e-06	2.53e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.33e-06	2.53e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.33e-06	2.53e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CALM1—Alzheimer's disease	2.32e-06	2.52e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	2.32e-06	2.52e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	2.32e-06	2.52e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	2.32e-06	2.52e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APOE—Alzheimer's disease	2.31e-06	2.51e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	2.31e-06	2.51e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	2.31e-06	2.51e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	2.3e-06	2.5e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.3e-06	2.5e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	2.3e-06	2.5e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	2.29e-06	2.49e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CAV1—Alzheimer's disease	2.29e-06	2.49e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.28e-06	2.48e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	2.27e-06	2.47e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	2.27e-06	2.47e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—Alzheimer's disease	2.27e-06	2.46e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	2.26e-06	2.46e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	2.22e-06	2.41e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—F2—Alzheimer's disease	2.19e-06	2.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	2.19e-06	2.38e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	2.17e-06	2.36e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	2.17e-06	2.36e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.16e-06	2.35e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.14e-06	2.33e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	2.13e-06	2.32e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—LPL—Alzheimer's disease	2.11e-06	2.29e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LPL—Alzheimer's disease	2.1e-06	2.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	2.08e-06	2.26e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—Alzheimer's disease	2.08e-06	2.26e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	2.06e-06	2.24e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.04e-06	2.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	2.04e-06	2.22e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.02e-06	2.2e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PPARG—Alzheimer's disease	2.02e-06	2.19e-05	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.01e-06	2.18e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.01e-06	2.18e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	1.99e-06	2.17e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	1.99e-06	2.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	1.99e-06	2.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—INS—Alzheimer's disease	1.98e-06	2.15e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.98e-06	2.15e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	1.98e-06	2.15e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—INS—Alzheimer's disease	1.98e-06	2.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.97e-06	2.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.97e-06	2.15e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.96e-06	2.13e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	1.95e-06	2.12e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1.95e-06	2.12e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	1.93e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.92e-06	2.08e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—Alzheimer's disease	1.91e-06	2.08e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.91e-06	2.07e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	1.9e-06	2.06e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.89e-06	2.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	1.89e-06	2.06e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.87e-06	2.03e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.85e-06	2.01e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.83e-06	1.99e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.83e-06	1.98e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.82e-06	1.98e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—LPL—Alzheimer's disease	1.78e-06	1.94e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	1.77e-06	1.93e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOE—Alzheimer's disease	1.77e-06	1.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	1.77e-06	1.92e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-06	1.92e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.76e-06	1.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	1.76e-06	1.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	1.76e-06	1.91e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	1.75e-06	1.9e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	1.75e-06	1.9e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	1.74e-06	1.89e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.74e-06	1.89e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	1.74e-06	1.89e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NOS3—Alzheimer's disease	1.73e-06	1.88e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.71e-06	1.85e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.7e-06	1.85e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.69e-06	1.84e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	1.68e-06	1.82e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—F2—Alzheimer's disease	1.66e-06	1.8e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.62e-06	1.76e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	1.61e-06	1.74e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	1.61e-06	1.74e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-06	1.74e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.59e-06	1.73e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.59e-06	1.72e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—Alzheimer's disease	1.59e-06	1.72e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—LPL—Alzheimer's disease	1.55e-06	1.69e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.55e-06	1.69e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	1.54e-06	1.67e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.53e-06	1.66e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	1.52e-06	1.66e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.51e-06	1.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	1.51e-06	1.64e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—INS—Alzheimer's disease	1.51e-06	1.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—INS—Alzheimer's disease	1.5e-06	1.63e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	1.5e-06	1.63e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOE—Alzheimer's disease	1.49e-06	1.62e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.49e-06	1.62e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-06	1.61e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	1.48e-06	1.61e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	1.48e-06	1.61e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.48e-06	1.6e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.47e-06	1.59e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	1.45e-06	1.58e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.45e-06	1.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.43e-06	1.56e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.43e-06	1.56e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.41e-06	1.53e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.4e-06	1.52e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-06	1.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.36e-06	1.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.35e-06	1.47e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.33e-06	1.45e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	1.32e-06	1.44e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.32e-06	1.43e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.31e-06	1.42e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.31e-06	1.42e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOE—Alzheimer's disease	1.3e-06	1.41e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	1.3e-06	1.41e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.29e-06	1.4e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	1.28e-06	1.39e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—INS—Alzheimer's disease	1.28e-06	1.39e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.26e-06	1.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.25e-06	1.36e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.22e-06	1.33e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.22e-06	1.33e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.22e-06	1.32e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.21e-06	1.31e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.21e-06	1.31e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	1.17e-06	1.27e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.15e-06	1.25e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.13e-06	1.23e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.13e-06	1.23e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	1.22e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.12e-06	1.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.12e-06	1.22e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—INS—Alzheimer's disease	1.11e-06	1.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.11e-06	1.21e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.08e-06	1.17e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.06e-06	1.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.05e-06	1.14e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.05e-06	1.14e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.04e-06	1.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.03e-06	1.12e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.03e-06	1.11e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	1.03e-06	1.11e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.02e-06	1.11e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NOS3—Alzheimer's disease	9.75e-07	1.06e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LPL—Alzheimer's disease	9.57e-07	1.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	9.49e-07	1.03e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	9.46e-07	1.03e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	9.46e-07	1.03e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	9.11e-07	9.9e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	8.92e-07	9.69e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	8.71e-07	9.47e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	8.66e-07	9.41e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	8.62e-07	9.36e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	8.33e-07	9.06e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	8.05e-07	8.75e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.02e-07	8.72e-06	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	7.99e-07	8.68e-06	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—Alzheimer's disease	7.97e-07	8.66e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.95e-07	8.64e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	7.17e-07	7.79e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.99e-07	7.59e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—INS—Alzheimer's disease	6.85e-07	7.45e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	6.57e-07	7.13e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	6.08e-07	6.61e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	6.06e-07	6.58e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.01e-07	6.53e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.5e-07	5.97e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	5.15e-07	5.59e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—Alzheimer's disease	4.48e-07	4.87e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	4.19e-07	4.55e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.76e-07	3e-06	CbGpPWpGaD
